Latest Amyloid precursor protein Stories
Alzheimer's disease is widely believed to be caused by the gradual accumulation in the brain of amyloid-beta peptide which is toxic to nerve cells.
Scientists at the Gladstone Institute of Neurological Disease (GIND) have offered new information about the events that underlie the "spread" of Alzheimer's disease (AD) throughout the brain.
New research is helping to unravel the events that underlie the "spread" of Alzheimer's disease (AD) throughout the brain.
Scientists at the Gladstone Institute of Neurological Disease (GIND) have offered new information about the events that underlie the â€œspreadâ€ of Alzheimer's disease throughout the brain.
Mount Sinai School of Medicine researchers have found that a gene associated with the onset of Type 2 diabetes also is found at lower-than-normal levels in people with Alzheimer's disease.
Massachusetts General Hospital researchers say they have determined how iron contributes to the production of brain-destroying plaques found in Alzheimer's patients.
As researchers try to understand how a particular protein sets the stage for the toxic plaques that wreak havoc on the brains of people with Alzheimerâ€™s disease, they face a dilemma.
SARASOTA, Fla., Sept. 27 /PRNewswire-USNewswire/ -- Scientists at the Roskamp Institute in Sarasota, Florida, have shown that mice that naturally develop Alzheimer's are able to ward off the growth of brain cancer.
Neurological researchers at Rush University Medical Center have found a new therapeutic target that can potentially lead to a new way to prevent the progression of Alzheimer's disease.
An international team of Alzheimerâ€™s disease experts, led by Washington University School of Medicine in St. Louis, has uncovered a gene variation that appears to predict the rate at which Alzheimerâ€™s disease will progress.
- totally perplexed and mixed up.